The Danish and European medical cannabis industry is at a key inflection point. More European countries are adopting medical cannabis as an option for patients but also as an emerging industry that creates high-quality jobs from pharma to nursery production, drives exports, and attracts investment.
The future shape of these industries is still unknown, with no common European model to set the scope of development. National regulations and priorities continue to set the framework, with each country pursuing different priorities, regulations, and market structures.
After an experimental pilot program from 2018 to 2021, the Danish government established a permanent framework for medical cannabis production that started in 2022. A permanent framework reduces investment risk while also opening new opportunities for the development of new plant genetics, API production, and manufacturing final products.
The Danish medical cannabis industry is based on a medical cannabis model, with an open-ended licensing regime based on high quality standards but no limits to the scale of production. This model has made Denmark into a leading centre for medical cannabis production and aligns with the broader Life Sciences industry, which accounted for over 22 percent of Denmark’s exports in 2021.
In the broader Life Sciences industry, Denmark is a leading nation for R&D expenditure, clinical research, and drug development. This expertise provides a solid basis for the medical cannabis industry to draw on the strengths of the Danish Life Sciences industry. But it requires partnerships between industry and research to increase longer-term collaboration in research and development to commercial scientific results.
This is theme of the 3rd Annual Symposium on Medical Cannabis, hosted by the Danish Technological Institute and Invest in Denmark: Knowledge transfer - Science to Industry. The theme of this year’s Symposium on Medical Cannabis relates to the role of science and technology in building medical cannabis industry.
As has been the case every year, the Symposium is based on understanding the value chain “From Plant to Patient” and involves creating links between the various stakeholders that are involved in this dynamic industry.
Invest in Denmark – National investment promotion agency under the Ministry of Foreign Affairs, Invest in Denmark has been actively involved in attracting medical cannabis investments into the Danish ecosystem, generating jobs and economic growth across Denmark.
Danish Technological Institute (GTS) transferring science to industry. For more than 112 years the Institute is supporting the Danish industry with new technology and innovations. Center for Bioressourcer working on optimized plants production indoor and in tissue culture as well as conducting breeding methods as using side streams for circular production.
The conference ends at 16.30. If you would like to participate in the following conference dinner, please choose the option 'conference dinner' under registration. The dinner costs 350 DKK.
Invest in Denmark – National investment promotion agency under the Ministry of Foreign Affairs, Invest in Denmark has been actively involved in attracting medical cannabis investments into the Danish ecosystem as support for the development scheme, including some of the largest cultivators in the world.
Danish Technological Institute (GTS) transferring science to industry. For more than 100 years the Institute is supporting the Danish industry with new technology and innovations. Center for Plant Technology has the focus on plant production, breeding and pathogens.
Taastrup 30. november 2022 |
Unikke tilbud, relevante artikler og nyt om vores kurser og uddannelser.
Der er desværre en systemfejl på nuværende tidspunkt. Du kan alternativt skrive en mail til data@teknologisk.dk
